J&J Stock Drops as Earnings Expected to Decline Next Quarter Amid Industry Headwinds
-
Johnson & Johnson (JNJ) stock has lagged the market recently, with a 1.41% daily drop vs 0.12% for the S&P 500.
-
JNJ earnings per share are expected to decrease 1.49% year-over-year to $2.64 next quarter. Revenue is projected to drop 13.59% to $21.38 billion.
-
For the full year, analysts forecast EPS growth of 7.36% to $10.65 and a revenue decline of 4.99% to $88.38 billion.
-
JNJ holds a Zacks Rank of #3 (Hold) currently and trades at a Forward P/E of 15.22, representing a premium to its industry average.
-
The Large Cap Pharmaceuticals industry ranks in the bottom 30% of Zacks industries, according to the Zacks Industry Rank system.